In this commentary from Commonwealth Medicine, Warren Smith, PharmD, discusses the US Food and Drug Administration's accelerated approval pathway with regard to its history, recent controversies, and potential improvements.
In this commentary from Commonwealth Medicine, Warren Smith, PharmD, discusses the US Food and Drug Administration's accelerated approval pathway with regard to its history, recent controversies, and potential improvements.
In this commentary from...